Our Curious Amalgam cover image

#295 More or (Even) Less Certainty in EU Merger Control? The European Court of Justice Judgment in Illumina/GRAIL

Our Curious Amalgam

00:00

Navigating Uncertainty in EU Merger Regulation

This chapter examines the impact of the European Commission's revised Article 22 referral procedure on pharmaceutical mergers, emphasizing the resulting uncertainty for companies and legal practitioners. The discussion highlights the challenges posed by the Illumina/GRAIL case and the broader implications of recent shifts in merger control law within the EU.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app